Now showing items 21-26 of 26

    • Regulation of T Cell Differentiation and Function by EZH2 

      Karantanos, Theodoros; Chistofides, Anthos; Barhdan, Kankana; Li, Lequn; Boussiotis, Vassiliki A. (Frontiers Media S.A., 2016)
      The enhancer of zeste homolog 2 (EZH2), one of the polycomb-group proteins, is the catalytic subunit of Polycomb-repressive complex 2 (PRC2) and induces the trimethylation of the histone H3 lysine 27 (H3K27me3) promoting ...
    • A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes 

      Jones, R. Brad; Mueller, Stefanie; O’Connor, Rachel; Rimpel, Katherine; Sloan, Derek D.; Karel, Dan; Wong, Hing C.; Jeng, Emily K.; Thomas, Allison S.; Whitney, James B.; Lim, So-Yon; Kovacs, Colin; Benko, Erika; Karandish, Sara; Huang, Szu-Han; Buzon, Maria J.; Lichterfeld, Mathias; Irrinki, Alivelu; Murry, Jeffrey P.; Tsai, Angela; Yu, Helen; Geleziunas, Romas; Trocha, Alicja; Ostrowski, Mario A.; Irvine, Darrell J.; Walker, Bruce D. (Public Library of Science, 2016)
      Resting CD4+ T-cells harboring inducible HIV proviruses are a critical reservoir in antiretroviral therapy (ART)-treated subjects. These cells express little to no viral protein, and thus neither die by viral cytopathic ...
    • T Cell Costimulatory and Coinhibitory Pathways in Vascular Inflammatory Diseases 

      Lichtman, Andrew Harry (Frontiers Research Foundation, 2012)
      A broad array of evidence indicates that T lymphocytes make significant contributions to vascular inflammation in the setting of atherosclerotic disease, hypertension, autoimmune vasculitis, and other disorders. Experimental ...
    • Targeting cancer stem cells with p53 modulators 

      Zhang, Zhan; Liu, Ling; Gomez-Casal, Roberto; Wang, Xinhui; Hayashi, Ryo; Appella, Ettore; Kopelovich, Levy; DeLeo, Albert B. (Impact Journals LLC, 2016)
      Cancer stem cells (CSC) typically over-express aldehyde dehydrogenase (ALDH). Thus, ALDHbright tumor cells represent targets for developing novel cancer prevention/treatment interventions. Loss of p53 function is a common ...
    • TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection 

      Jayaraman, Pushpa; Jacques, Miye K.; Zhu, Chen; Steblenko, Katherine M.; Stowell, Britni L.; Madi, Asaf; Anderson, Ana C.; Kuchroo, Vijay K.; Behar, Samuel M. (Public Library of Science, 2016)
      While T cell immunity initially limits Mycobacterium tuberculosis infection, why T cell immunity fails to sterilize the infection and allows recrudescence is not clear. One hypothesis is that T cell exhaustion impairs ...
    • Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours 

      Galon, Jérôme; Mlecnik, Bernhard; Bindea, Gabriela; Angell, Helen K; Berger, Anne; Lagorce, Christine; Lugli, Alessandro; Zlobec, Inti; Hartmann, Arndt; Bifulco, Carlo; Nagtegaal, Iris D; Palmqvist, Richard; Masucci, Giuseppe V; Botti, Gerardo; Tatangelo, Fabiana; Delrio, Paolo; Maio, Michele; Laghi, Luigi; Grizzi, Fabio; Asslaber, Martin; D'Arrigo, Corrado; Vidal-Vanaclocha, Fernando; Zavadova, Eva; Chouchane, Lotfi; Ohashi, Pamela S; Hafezi-Bakhtiari, Sara; Wouters, Bradly G; Roehrl, Michael; Nguyen, Linh; Kawakami, Yutaka; Hazama, Shoichi; Okuno, Kiyotaka; Ogino, Shuji; Gibbs, Peter; Waring, Paul; Sato, Noriyuki; Torigoe, Toshihiko; Itoh, Kyogo; Patel, Prabhu S; Shukla, Shilin N; Wang, Yili; Kopetz, Scott; Sinicrope, Frank A; Scripcariu, Viorel; Ascierto, Paolo A; Marincola, Francesco M; Fox, Bernard A; Pagès, Franck (John Wiley & Sons, Ltd, 2013)
      The American Joint Committee on Cancer/Union Internationale Contre le Cancer (AJCC/UICC) TNM staging system provides the most reliable guidelines for the routine prognostication and treatment of colorectal carcinoma. This ...